MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

Schulich Medicine & Dentistry's Rapport magazine, Issue Four Summer 2009

Release issued 9th September 2009

Read Shulich Medicine & Dentistry's Rapport magazine, Issue Four Summer 2009.

 

Company details

If you want to find out more about the company visit WORLDiscoveries profile.

Latest WORLDiscoveries press releases

(20th November 2009) Gaining a better picture of lung disease

(19th November 2009) Postovit named Premier Young Researcher

(19th November 2009) Time to ramp up health innovation

(19th November 2009) Hess named HSFC Highest-Rated New Investigator

(16th November 2009) Hachinski elected president of World Federation of Neurology

More Press Releases

Latest

Gaining a better picture of lung disease
Hess named HSFC Highest-Rated New Investigator
Time to ramp up health innovation
Postovit named Premier Young Researcher
Hachinski elected president of World Federation of Neurology

Most viewed

TDS® TESTOSTERONE EXCEEDS ANDROGEL® OUTCOMES
GenMont probiotics products receive China market entry approval
Surveyed neurologists in both the United States and Europe indicate that a once-daily transdermal formulation of Levodopa would earn a 30 percent patient share in Parkinson’s Disease
TDS® TESTOSTERONE WILL LIKELY NOT REQUIRE BLACK BOX WARNINGS FROM FDA
Medigreen announces MAF, a new botanical-based anti-allergy formulation

Related categories

Therapeutic target
Cardiovascular
Hospital and Surgery
Transplantation
Industry sector
Academic/Research
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Universities
Pharmaceutical

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us